CC BY-NC-ND 4.0 · Journal of Academic Ophthalmology 2021; 13(02): e256-e263
DOI: 10.1055/s-0041-1733939
Research Article

Perceptions of a Virtual Interview Exercise for Ophthalmology Residency Applicants

Bilal Ahmed
1   University of Toledo College of Medicine and Life Sciences, Toledo, Ohio
,
Victoria Ly
2   University of Arkansas for Medical Science, Little Rock, Arkansas
,
Ankur Parikh
3   Northeast Ohio Medical University, Rootstown, Ohio
,
Arjun Watane
4   Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, Florida
,
Sanah Aslam
5   Medical College of Georgia, Augusta, Georgia
,
Anjalee Choudhury
6   University of Texas Rio Grande Valley School of Medicine, El Paso, Texas
,
Benjamin Lin
4   Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, Florida
,
Yoshihiro Yonekawa
7   Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, Pennsylvania
,
Jayanth Sridhar
4   Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, Florida
› Author Affiliations

Abstract

Importance In-person interviews have traditionally been considered a crucial component of the residency application process. Virtual interviews (VIs) became the standard format for the 2020 to 2021 application cycle due to the novel coronavirus disease 2019 (COVID-19) pandemic. VIs offer a new perspective and challenge to this process which warrants unique considerations and further understanding of effects on applicants.

Objective This study aimed to assess the perceived efficacy of a VI preparedness exercise for ophthalmology residency applicants in the 2021 residency application cycle.

Design, Setting, and Participants A cross-sectional survey was distributed online. All participants in a mock VI exercise conducted via video-telecommunication technology were invited to complete the survey. Data collection occurred from October 12, 2020, to November 2, 2020. A follow-up survey after a match results released was distributed to all participants and data collection occurred from February 18, 2021, to February 25, 2021.

Main Outcome and Measures Applicant demographics, comfort, and attitudes toward VIs and VI practice were the primary measurements of this study.

Results Responses to the initial survey were received from all 35 participants (100%) in the VI mock interviews. There was a statistically significant difference between the pre- and postinterview responses for “How prepared do you feel for virtual interviews with residency programs?” (p = 0.0003) and “How likely are you to practice virtual interviews with someone you know?” (p = 0.0023). Participants reported feeling more prepared for VIs with residency programs after the mock interview (p = 0.002). A greater proportion of participants responded with “Very Likely” after the mock interview in comparison to before the interview to the questions “How likely are you to practice interviews with someone you know?” (p = 0.039) and “How likely are you to practice virtual interviews in the same room/area as you will during the official interview season?” (p = 0.021). Of the 35 original participants, 20 completed the follow-up survey. There were an equal number of participants who responded either “Helped Somewhat” (n = 9) or “Helped Greatly” (n = 9) to “How much did the VI mock exercise help you for the actual interview season?” in the follow-up survey. The majority of follow-up survey respondents (17/20) reported that they had additional practice in the virtual environment for interviews after the VI mock exercise. There was no significant difference in perceived helpfulness of the VI mock exercise during the actual interview season between matched and unmatched participants.

Conclusion and Relevance As residency applicants prepare for future VIs, practice and adequate preparation will be essential. In this study, implementation of a VI preparedness exercise had a positive impact on applicants' perception of their preparedness and intention to practice the format in the future.

Financial Support

This study was supported by National Institute of Health (NIH) Center Core Grant, grant no.: P30EY014801, Research to Prevent Blindness Unrestricted Grant (Bascom Palmer Eye Institute).


Disclosure

J.S. is a consultant for Alcon, Dorc, Regeneron, and Oxurion. Y.Y. is a consultant for Alcon, Alimera, Allergan, and Genentech. None of the other authors have any financial disclosures.




Publication History

Received: 27 December 2020

Accepted: 03 April 2021

Article published online:
11 December 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA